It was discovered early on that CXCR4 expression in melanoma cells was correlated with poor prognosis and the risk of recurrence was 2.5-fold higher and death 3 times higher than those with low CXCR4 expression [266]. This evidence concerns the gene CXCR4 and melanoma.